| Followers | 40 |
| Posts | 5751 |
| Boards Moderated | 0 |
| Alias Born | 04/12/2021 |
Wednesday, December 01, 2021 8:31:25 AM
Cnsp is being bid up by clowns premarket every day, or it is the FED propping up the market, no news and people are trying to create gaps premarket in many stocks, bull traps as the stock sells off all day, all imo
my posts are always theory and not financial advice
Recent CNSP News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/20/2026 01:03:22 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 05/19/2026 09:02:09 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/19/2026 08:55:38 PM
- CNS Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Strategic Transformation Progress • ACCESS Newswire • 05/14/2026 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2026 11:55:30 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/04/2026 11:05:18 AM
- CNS Pharmaceuticals Announces Oversubscribed $22.5 Million Private Placement Financing • ACCESS Newswire • 05/04/2026 11:00:00 AM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 04/30/2026 08:30:44 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 08:30:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2026 12:35:29 PM
- CNS Pharmaceuticals Launches New Corporate Strategy Focused on Building a High-Value Neurology and Oncology Pipeline • ACCESS Newswire • 03/11/2026 12:35:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 10:02:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/02/2026 10:00:26 PM
- CNS Pharmaceuticals Appoints Lynne Kelley, MD, FACS, as Chief Medical Officer, Completing Executive Leadership Team • ACCESS Newswire • 03/02/2026 01:25:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/27/2026 10:22:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 01:35:58 PM
- CNS Pharmaceuticals Appoints Multiple Key Executives to Drive Company's Recently Initiated Strategic Transformation • ACCESS Newswire • 02/17/2026 01:25:00 PM
- CNS Pharmaceuticals Issues Letter to Shareholders • ACCESS Newswire • 01/27/2026 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2026 10:01:02 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2026 10:00:04 PM
- CNS Pharmaceuticals Shares Dip After CEO Departure Announcement • IH Market News • 12/17/2025 03:12:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/17/2025 01:43:58 PM
- CNS Pharmaceuticals Announces CEO Transition • ACCESS Newswire • 12/17/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/21/2025 10:19:16 PM
